Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
A specific procurement under a dynamic purchasing system for the provision of potassium iodide tablets
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Accord-UK Ltd | 00079585 | - | 1 lot Antidotes and antibiotics | - |
| Aguettant Ltd | 04966231 | - | 1 lot Antidotes and antibiotics | - |
| Bayer Plc | - | - | 1 lot Antidotes and antibiotics | - |
| G.L. Pharma UK Limited | 11829209 | - | 1 lot Antidotes and antibiotics | - |
| Hameln Pharma Ltd | 01034697 | - | 1 lot Antidotes and antibiotics | - |
| Kent Pharma Ltd | - | - | 1 lot Antidotes and antibiotics | - |
| Medreich PLC | 03122988 | - | 1 lot Antidotes and antibiotics | - |
| Nationwide Healthcare Solutions LTD | 07278785 | - | 1 lot Antidotes and antibiotics | - |
This procurement was divided into 1 lots, each awarded separately. 54 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Antidotes and antibiotics 3,600 days (≈9.9 yrs) | £13 initial term | 2 | Hameln Pharma Ltd Accord-UK Ltd Kent Pharma Ltd Bayer Plc Aguettant Ltd Medreich PLC Nationwide Healthcare Solutions LTD KENT PHARMA UK LIMITED G.L. Pharma UK Limited | active |
Weightings from the notice.
Government spending data: These suppliers have received £10,142,518 in 1,414 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care, NHS England, Guy's and St Thomas' NHS FT (2010-04-15 to 2026-02-13).
Changes the buyer published to this notice after it first appeared.
Reason for change:
As a result of reforms to the public health system, set out in the Policy Paper 'Transforming the public health system: reforming the public health system for the challenges of our time' published on 29 March 2021, Public Health England, an executive agency of the Department of Health and Social Care (PHE), closed at the end of September 2021. As of 1 October 2021, responsibility for the management of the DPS CM/EMP/21/21025 has transferred from PHE to the new UK Health Security Agency (UKHSA) which is also an executive agency of the Department of Health and Social Care. This Corrigendum notifies the market of the change of Authority responsible for the DPS CM/EMP/21/21025 from the Secretary of State for Health and Social Care acting as part of the Crown through Public Health England to the Secretary of State for Health and Social Care acting as part of the Crown through the UK Health Security Agency. For the avoidance of doubt, the change referred to in this Corrigendum became effective on 1 October 2021.
Reason for change:
As a result of reforms to the public health system, set out in the Policy Paper 'Transforming the public health system: reforming the public health system for the challenges of our time' published on 29 March 2021, Public Health England, an executive agency of the Department of Health and Social Care (PHE), closed at the end of September 2021. As of 1 October 2021, responsibility for the management of the DPS CM/EMP/21/21025 has transferred from PHE to the new UK Health Security Agency (UKHSA) which is also an executive agency of the Department of Health and Social Care. This Corrigendum notifies the market of the change of Authority responsible for the DPS CM/EMP/21/21025 from the Secretary of State for Health and Social Care acting as part of the Crown through Public Health England to the Secretary of State for Health and Social Care acting as part of the Crown through the UK Health Security Agency. For the avoidance of doubt, the change referred to in this Corrigendum became effective on 1 October 2021.
Published by the buyer on this notice. Check the original notice — details change and are not updated here.